Largest health care companies
The 1,021 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.082 T
9.2% of all US-listed value
Companies
1,021
Ranked #4 of 12 sectors
Average
$8.895 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.07T | $1,138.28 | +2.02% | United States |
| 2 | Johnson & JohnsonJNJ | $641.8B | $266.32 | +0.28% | United States |
| 3 | AbbVieABBV | $462.6B | $261.77 | +1.81% | United States |
| 4 | Merck & Co.MRK | $357.4B | $144.85 | +0.64% | United States |
| 5 | UnitedHealth GroupUNH | $344.3B | $383.55 | +1.18% | United States |
| 6 | Philip Morris InternationalPM | $303.7B | $194.86 | +1.99% | United States |
| 7 | NovartisNVS | $265.2B | $138.99 | +1.33% | Switzerland |
| 8 | AstrazenecaAZN | $254.0B | $163.78 | +2.25% | United Kingdom |
| 9 | AmgenAMGN | $206.3B | $381.50 | +1.10% | United States |
| 10 | Novo Nordisk A SNVO | $192.4B | $43.45 | +0.88% | Denmark |
| 11 | Gilead SciencesGILD | $181.5B | $146.41 | +1.87% | United States |
| 12 | Abbott LaboratoriesABT | $178.4B | $103.09 | +1.12% | United States |
| 13 | PfizerPFE | $158.0B | $27.72 | +0.00% | United States |
| 14 | Intuitive SurgicalISRG | $133.5B | $377.94 | +2.38% | United States |
| 15 | Vertex PharmaceuticalsVRTX | $131.7B | $519.51 | +0.79% | United States |
| 16 | Bristol Myers SquibbBMY | $130.9B | $64.10 | +0.72% | United States |
| 17 | British American Tobacco p.l.c.BTI | $123.8B | $57.29 | +3.71% | United Kingdom |
| 18 | MedtronicMDT | $120.0B | $93.80 | +3.12% | United States |
| 19 | Altria GroupMO | $117.9B | $70.61 | +2.36% | United States |
| 20 | StrykerSYK | $108.1B | $281.87 | +2.29% | United States |
| 21 | McKessonMCK | $106.2B | $910.95 | +3.34% | United States |
| 22 | SanofiSNY | $105.7B | $43.33 | +1.31% | France |
| 23 | GSKGSK | $101.2B | $50.05 | +3.99% | United Kingdom |
| 24 | HCA HealthcareHCA | $92.1B | $425.49 | -0.34% | United States |
| 25 | Elevance HealthELV | $92.0B | $424.24 | +1.32% | United States |
| 26 | 3MMMM | $83.6B | $162.02 | -1.79% | United States |
| 27 | Regeneron PharmaceuticalsREGN | $81.7B | $793.74 | +1.57% | United States |
| 28 | Cigna GroupCI | $76.6B | $290.05 | +3.31% | United States |
| 29 | Boston ScientificBSX | $65.3B | $45.05 | +4.82% | United States |
| 30 | CencoraCOR | $62.3B | $326.23 | +1.45% | United States |
| 31 | Argenx SeARGX | $61.5B | $990.54 | +0.63% | Netherlands |
| 32 | Takeda PharmaceuticalTAK | $58.8B | $18.60 | +1.86% | Japan |
| 33 | ModernaMRNA | $58.6B | $146.69 | +1.89% | United States |
| 34 | Cardinal HealthCAH | $54.6B | $234.89 | +0.14% | United States |
| 35 | Becton Dickinson & CoBDX | $49.8B | $182.91 | +2.85% | United States |
| 36 | Edwards LifesciencesEW | $49.3B | $85.52 | +1.36% | United States |
| 37 | NateraNTRA | $49.3B | $341.79 | +3.91% | United States |
| 38 | HumanaHUM | $48.9B | $407.02 | -0.68% | United States |
| 39 | Teva Pharmaceutical IndustriesTEVA | $45.1B | $38.72 | +4.39% | Israel |
| 40 | Revolution MedicinesRVMD | $44.0B | $205.11 | +0.66% | United States |
| 41 | IqviaIQV | $43.7B | $265.67 | +1.49% | United States |
| 42 | MedlineMDLN | $42.8B | $32.59 | +0.18% | United States |
| 43 | BeOne MedicinesONC | $40.2B | $353.83 | +2.11% | Cayman Islands |
| 44 | Idexx LaboratoriesIDXX | $40.1B | $509.56 | +0.96% | United States |
| 45 | CenteneCNC | $34.3B | $69.41 | +4.50% | United States |
| 46 | Royalty PharmaRPRX | $34.0B | $59.05 | +0.75% | United States |
| 47 | AlconALC | $33.8B | $67.74 | +2.59% | Switzerland |
| 48 | Alnylam PharmaceuticalsALNY | $33.5B | $249.99 | +0.53% | United States |
| 49 | ResmedRMD | $32.2B | $222.99 | +2.16% | United States |
| 50 | BiogenBIIB | $32.1B | $217.36 | +0.10% | United States |
| 51 | DexcomDXCM | $32.0B | $84.68 | +1.99% | United States |
| 52 | IlluminaILMN | $31.4B | $208.21 | +0.85% | United States |
| 53 | ZoetisZTS | $30.4B | $73.67 | +0.96% | United States |
| 54 | Roivant SciencesROIV | $29.6B | $41.02 | +0.49% | United Kingdom |
| 55 | GE HealthCare TechnologiesGEHC | $29.0B | $64.25 | +0.50% | United States |
| 56 | InsmedINSM | $27.4B | $125.30 | -3.18% | United States |
| 57 | Quest DiagnosticsDGX | $26.3B | $237.89 | +1.22% | United States |
| 58 | LabcorpLH | $25.6B | $315.31 | +1.21% | United States |
| 59 | West Pharmaceutical ServicesWST | $25.0B | $355.20 | +2.59% | United States |
| 60 | BioNTech SEBNTX | $24.8B | $98.86 | +2.20% | Germany |
| 61 | IncyteINCY | $24.8B | $122.19 | +0.59% | United States |
| 62 | Koninklijke PhilipsPHG | $24.7B | $25.08 | +1.99% | Netherlands |
| 63 | Guardant HealthGH | $22.5B | $167.84 | +6.65% | United States |
| 64 | United TherapeuticsUTHR | $21.6B | $502.70 | +1.12% | United States |
| 65 | Tenet HealthcareTHC | $21.3B | $264.51 | +0.31% | United States |
| 66 | STERISSTE | $20.8B | $213.66 | +1.38% | United States |
| 67 | ViatrisVTRS | $19.1B | $16.66 | +0.91% | United States |
| 68 | Zimmer BiometZBH | $18.4B | $96.54 | +3.26% | United States |
| 69 | Ascendis Pharma A/SASND | $17.4B | $264.92 | +0.53% | Denmark |
| 70 | MedpaceMEDP | $16.6B | $595.41 | +1.34% | United States |
| 71 | Neurocrine BiosciencesNBIX | $16.0B | $157.22 | +0.64% | United States |
| 72 | Jazz PharmaceuticalsJAZZ | $16.0B | $245.87 | +0.03% | Ireland |
| 73 | SolventumSOLV | $15.3B | $89.82 | +2.71% | United States |
| 74 | Summit TherapeuticsSMMT | $14.7B | $18.42 | +4.96% | United States |
| 75 | BridgeBio PharmaBBIO | $14.1B | $72.38 | -0.08% | United States |
| 76 | UL SolutionsULS | $14.0B | $69.50 | -2.46% | United States |
| 77 | ExelixisEXEL | $13.9B | $56.21 | +0.16% | United States |
| 78 | Charles River Laboratories InternationalCRL | $13.0B | $273.11 | -1.85% | United States |
| 79 | IconICLR | $12.9B | $168.93 | -0.22% | Ireland |
| 80 | Biomarin PharmaceuticalBMRN | $12.9B | $66.41 | +1.11% | United States |
| 81 | Fresenius Medical CareFMS | $12.8B | $22.86 | +2.28% | Germany |
| 82 | PenumbraPEN | $12.6B | $319.86 | +0.67% | United States |
| 83 | Madrigal PharmaceuticalsMDGL | $12.5B | $540.06 | +1.04% | United States |
| 84 | Baxter InternationalBAX | $12.3B | $23.86 | +0.25% | United States |
| 85 | Halozyme TherapeuticsHALO | $12.3B | $107.94 | +0.69% | United States |
| 86 | Encompass HealthEHC | $12.1B | $122.53 | +0.67% | United States |
| 87 | Corcept TherapeuticsCORT | $12.1B | $111.80 | -0.88% | United States |
| 88 | DavitaDVA | $12.1B | $189.32 | +4.28% | United States |
| 89 | BrightSpring Health ServicesBTSG | $11.9B | $60.30 | +2.67% | United States |
| 90 | Smith & NephewSNN | $11.9B | $28.40 | +3.27% | United Kingdom |
| 91 | Elanco Animal HealthELAN | $11.6B | $23.15 | -0.09% | United States |
| 92 | Arrowhead PharmaceuticalsARWR | $11.4B | $80.67 | -2.63% | United States |
| 93 | Axsome TherapeuticsAXSM | $11.3B | $216.58 | -1.89% | United States |
| 94 | Bio-TechneTECH | $11.3B | $72.27 | +0.21% | United States |
| 95 | Molina HealthcareMOH | $11.2B | $214.07 | +4.82% | United States |
| 96 | Align TechnologyALGN | $10.9B | $153.00 | +1.45% | United States |
| 97 | Oscar HealthOSCR | $10.4B | $33.81 | +3.17% | United States |
| 98 | Cooper CompaniesCOO | $10.3B | $54.22 | +0.57% | United States |
| 99 | Universal Health ServicesUHS | $10.2B | $173.25 | -0.90% | United States |
| 100 | Ensign GroupENSG | $10.2B | $174.93 | +0.55% | United States |
Showing the largest 100 of 1,021 companies. One row per company, with secondary share classes folded into their primary listing. Updated 15 Sept 2026.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Medical Specialities 43Biotechnology: Biological Products (No Diagnostic Substances) 159Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 30Other Pharmaceuticals 11Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 28Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Ophthalmic Goods 8Medical Electronics 5Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.